Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dechra Pharmaceuticals PLC Remuneration Information 2018

Sep 17, 2018

4797_rns_2018-09-17_d52b3e06-d753-4e3e-ba06-bacd6e34b14b.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9585A

Dechra Pharmaceuticals PLC

17 September 2018

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 17 September 2018

Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: Long-Term Incentive Scheme
Period of return: From: 15 March 2018 To: 14 September 2018
Balance of unallotted securities under scheme(s) from previous return: 249
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 156,000
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): Nil
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 156,249
Name of contact: Melanie Hall
Telephone number of contact: 01606 814730

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 17 September 2018

Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: Approved Share Option Scheme
Period of return: From: 15 March 2018 To: 14 September 2018
Balance of unallotted securities under scheme(s) from previous return: 22,214
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 2,745
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 19,469
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 17 September 2018

Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: Unapproved Share Option Scheme
Period of return: From: 15 March 2018 To: 14 September 2018
Balance of unallotted securities under scheme(s) from previous return: 73,706
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 36,000
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 19,266
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 90,440
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 17 September 2018

Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: SAYE Scheme
Period of return: From: 15 March 2018 To: 14 September 2018
Balance of unallotted securities under scheme(s) from previous return: 5,622
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 14,000
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 5,968
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 13,654
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRLIFIAALIDLIT